TW200738239A - Stable solid formulation of sertindole - Google Patents

Stable solid formulation of sertindole

Info

Publication number: TW200738239A
Authority: TW; Taiwan
Prior art keywords: sertindole; solid formulation; stable solid; pharmaceutical composition; relates
Prior art date: 2005-09-08

Application number

TW095130202A

Other languages

English (en)

Chinese (zh)

Inventor

Flemming Enok Olsen

Anne Ravnholdt Christensen

Ken Liljegren

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-08

Filing date

2006-08-17

Publication date

2007-10-16

2006-08-17 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2007-10-16 Publication of TW200738239A publication Critical patent/TW200738239A/zh

Links

GZKLJWGUPQBVJQ-UHFFFAOYSA-N sertindole Chemical compound C1=CC(F)=CC=C1N1C2=CC=C(Cl)C=C2C(C2CCN(CCN3C(NCC3)=O)CC2)=C1 GZKLJWGUPQBVJQ-UHFFFAOYSA-N 0.000 title abstract 4
229960000652 sertindole Drugs 0.000 title abstract 4
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000007787 solid Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 2
239000003223 protective agent Substances 0.000 abstract 2
239000011247 coating layer Substances 0.000 abstract 1
JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 abstract 1
229960005191 ferric oxide Drugs 0.000 abstract 1
UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 abstract 1
235000013980 iron oxide Nutrition 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
230000005855 radiation Effects 0.000 abstract 1
201000000980 schizophrenia Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Inorganic Chemistry (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

TW095130202A 2005-09-08 2006-08-17 Stable solid formulation of sertindole TW200738239A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200501255		2005-09-08

Publications (1)

Publication Number	Publication Date
TW200738239A true TW200738239A (en)	2007-10-16

Family

ID=37697999

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW095130202A TW200738239A (en)	2005-09-08	2006-08-17	Stable solid formulation of sertindole

Country Status (17)

Country	Link
EP (1)	EP1924261A1 (pt)
JP (1)	JP2009507051A (pt)
KR (1)	KR20080042102A (pt)
CN (1)	CN101257906A (pt)
AR (1)	AR056475A1 (pt)
AU (1)	AU2006322460A1 (pt)
BR (1)	BRPI0615630A2 (pt)
CA (1)	CA2621866A1 (pt)
EA (1)	EA013167B1 (pt)
IL (1)	IL189541A0 (pt)
MX (1)	MX2008002290A (pt)
NO (1)	NO20081721L (pt)
NZ (1)	NZ565330A (pt)
TW (1)	TW200738239A (pt)
UA (1)	UA97349C2 (pt)
WO (1)	WO2007065448A1 (pt)
ZA (1)	ZA200801169B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI320783B (en)	2005-04-14	2010-02-21	Otsuka Pharma Co Ltd	Heterocyclic compound
KR20110117133A (ko) *	2009-01-29	2011-10-26	다이닛본 스미토모 세이야꾸 가부시끼가이샤	내핵을 갖는 구강 내 붕괴 정
FR2943061B1 (fr) *	2009-03-13	2011-02-25	Rhodia Operations	Composes organophosphores, systemes catalytiques comprenant ces composes et procede d'hydrocyanation ou d'hydroformylation utilisant ces systemes catalytiques
US8883823B2 (en)	2012-07-16	2014-11-11	Fibrogen, Inc.	Crystalline forms of a prolyl hydroxylase inhibitor
AU2013290438C1 (en)	2012-07-16	2019-01-03	Kyntra Bio, Inc.	Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
HRP20200615T1 (hr) *	2013-06-06	2020-07-10	Fibrogen, Inc.	Farmaceutske formulacije inhibitora hif hidroksilaze
WO2015077143A1 (en)	2013-11-19	2015-05-28	Siga Technologies, Inc.	Rehydration of micronized tecovirimat monohydrate
JP2018172361A (ja) *	2016-10-14	2018-11-08	大原薬品工業株式会社	光安定性を改善した、デュロキセチンを含有する固形製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH04346929A (ja) *	1991-05-22	1992-12-02	Takada Seiyaku Kk	光に安定なメシル酸ブロモクリプチン製剤
EP0906104A4 (en) *	1996-03-25	2003-12-10	Lilly Co Eli	PAIN TREATMENT PROCESS
ZA973433B (en) *	1996-04-24	1997-12-10	Shionogi & Co	A sertindole-containing preparation and a method for producing the same.
ZA977967B (en) *	1996-09-23	1999-03-04	Lilly Co Eli	Combination therapy for treatment of psychoses

2006
- 2006-06-09 UA UAA200803569A patent/UA97349C2/uk unknown
- 2006-08-17 TW TW095130202A patent/TW200738239A/zh unknown
- 2006-08-29 AR ARP060103764A patent/AR056475A1/es not_active Application Discontinuation
- 2006-09-06 EA EA200800774A patent/EA013167B1/ru not_active IP Right Cessation
- 2006-09-06 MX MX2008002290A patent/MX2008002290A/es not_active Application Discontinuation
- 2006-09-06 NZ NZ565330A patent/NZ565330A/en not_active IP Right Cessation
- 2006-09-06 JP JP2008529472A patent/JP2009507051A/ja not_active Withdrawn
- 2006-09-06 CN CNA2006800323410A patent/CN101257906A/zh active Pending
- 2006-09-06 EP EP06846966A patent/EP1924261A1/en not_active Withdrawn
- 2006-09-06 CA CA002621866A patent/CA2621866A1/en not_active Abandoned
- 2006-09-06 ZA ZA200801169A patent/ZA200801169B/xx unknown
- 2006-09-06 AU AU2006322460A patent/AU2006322460A1/en not_active Abandoned
- 2006-09-06 WO PCT/DK2006/050038 patent/WO2007065448A1/en not_active Ceased
- 2006-09-06 BR BRPI0615630A patent/BRPI0615630A2/pt not_active IP Right Cessation
- 2006-09-06 KR KR1020087004910A patent/KR20080042102A/ko not_active Withdrawn
2008
- 2008-02-14 IL IL189541A patent/IL189541A0/en unknown
- 2008-04-08 NO NO20081721A patent/NO20081721L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
UA97349C2 (uk)	2012-02-10
CN101257906A (zh)	2008-09-03
NO20081721L (no)	2008-04-08
CA2621866A1 (en)	2007-06-14
KR20080042102A (ko)	2008-05-14
NZ565330A (en)	2011-06-30
EP1924261A1 (en)	2008-05-28
BRPI0615630A2 (pt)	2016-11-16
IL189541A0 (en)	2008-08-07
JP2009507051A (ja)	2009-02-19
ZA200801169B (en)	2010-07-28
AR056475A1 (es)	2007-10-10
AU2006322460A1 (en)	2007-06-14
EA013167B1 (ru)	2010-02-26
MX2008002290A (es)	2008-03-14
EA200800774A1 (ru)	2008-06-30
WO2007065448A1 (en)	2007-06-14

Similar Documents

Publication	Publication Date	Title
WO2006107451A3 (en)	2006-11-30	Honokiol derivatives for the treatment of proliferative disorders
CL2007003244A1 (es)	2008-04-04	Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
IL186303A (en)	2013-07-31	1h - benzamideimzole - 4 carboxyamides converted with quarterly carbon in position 2, the pharmaceutical composition containing it and its use for the preparation of a drug @ for the treatment @ of cancer
JP2006519866A5 (pt)	2007-03-22
WO2008097640A3 (en)	2008-10-02	Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
WO2007100776A3 (en)	2008-06-19	Antimicrobial compositions and methods for locking catheters
CL2007002017A1 (es)	2008-06-13	Compuestos derivados de [4,5']-bipirimidinil-6,4'-diamina; composicion farmaceutica; y uso como inhibidor de la actividad de cinasa en cancer de vejiga, cancer cervical y mieloma multiple.
CL2007002261A1 (es)	2008-05-02	Compuestos derivados de imidazo[1,2-b]piridazina, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion del cancer.
CL2008001024A1 (es)	2009-01-02	Compuestos derivados de ftalazinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades cardiovasculares, parkinson, enfermedades inflamatorias, esclerosis multiple, cancer, entre otras
BRPI0806531A2 (pt)	2014-04-22	Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
WO2008052005A3 (en)	2008-06-26	Compounds and methods for treating estrogen receptor-related diseases
BRPI0814593A2 (pt)	2015-01-20	Composto, composição farmacêutica que o contém e uso do composto.
BRPI0809667A2 (pt)	2014-10-07	Composto, medicamento e composição farmacêutica que o contém e uso do composto
CL2008003473A1 (es)	2009-08-14	Compuestos derivados de fenilpiperidina sustituidos por heterociclos; procedimiento de preparacion; composicion farmaceutica que lo comprende; y uso en el tratamiento del trastorno cardiovasculares, tromboembolicos y tumorales; usos in vitro.
JO2578B1 (en)	2011-02-27	Compounds Theophene benzimidazole
CL2007002207A1 (es)	2008-02-01	Compuestos derivados de sulfonilaminas; composicion farmaceutica; y uso de los compuestos en el tratamiento del glaucoma.
BRPI0813341A2 (pt)	2014-12-23	" uso de compostos, composições curáveis, e, uso de composições curáveis ".
CL2007002920A1 (es)	2008-06-06	Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
NO20081721L (no)	2008-04-08	Stabil fast formulering av sertindol
BR0318278A (pt)	2006-05-23	compostos de éter aminocicloexìlico e usos dos mesmo
BRPI0717369A2 (pt)	2014-10-07	Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2007003643A1 (es)	2008-03-24	Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas.
BR0313220A (pt)	2005-06-14	Pelìcula de revestimento para comprimidos e cápsulas
WO2006116221A3 (en)	2007-04-12	Therapeutic combinations for the treatment or prevention of psychotic disorders
CL2007003847A1 (es)	2008-04-18	Compuestos derivados de pirimidinas 2,4,5 tri-sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento del cancer.